# Sugammadex Efficacy and Safety for Reversal of Pipecuronium-induced Neuromuscular Blockade

> **NCT01424488** · PHASE4 · UNKNOWN · sponsor: **Central Clinical Hospital #1 of LLC Russian Railways** · enrollment: 42 (estimated)

## Conditions studied

- Adult Subjects Undergoing Abdominal Surgery Under General Anesthesia

## Interventions

- **DRUG:** sugammadex
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01424488
- **Lead sponsor:** Central Clinical Hospital #1 of LLC Russian Railways
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2011-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424488, "Sugammadex Efficacy and Safety for Reversal of Pipecuronium-induced Neuromuscular Blockade". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01424488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*